Article ID Journal Published Year Pages File Type
5698524 Clinical Oncology 2012 6 Pages PDF
Abstract
The regimen of weekly single agent paclitaxel is feasible in patients with locally advanced breast cancer with acceptable toxicity. It resulted in a pathological response rate that was comparable with other regimens in this group of advanced stage patients. Considering the efficacy and low toxicity of this regimen, it is worth exploring in larger studies.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , ,